Standard BioTools Inc (NAS:LAB)
$ 2.4 -0.01 (-0.41%) Market Cap: 909.27 Mil Enterprise Value: 900.16 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Fluidigm Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2020 / 07:00PM GMT
Release Date Price: $4.29 (-1.15%)
Brandon Couillard
Jefferies - Analyst

Good afternoon, everybody. Welcome to Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools and diagnostic sector, here at the firm, we're very happy to have Fluidigm with us back at the conference this year. And here to give us an update on what's going on, CEO, Chris Linthwaite. Chris?

Chris Linthwaite
Fluidigm Corporation - CEO

Thank you, Brandon, and thank you to Jefferies for including us in the 2020 Virtual Healthcare Conference, looking forward to this new milestone of conference approaches.

I'm just going to jump right into the Fluidigm Corporation story. So, you guys can track, as it's always the first test. Let's see. Okay.

So, of course, the presentation, we'll be making some forward-looking statements. For full disclosure of our forward-looking statements, please reference the Fluidigm website under the Investor Relations section. There will be also some non-GAAP financial information will be shared towards the end and use of trademarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot